Founded to serve health, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. Our unique governance model preserves our independence and means it can fully serve our vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Our 22,000 employees are fully committed to this shared vocation, which serves as a source of inspiration every day.
A world leader in cardiometabolism & venous diseases, we have made a major shift into oncology, which represents a new pillar of strategic growth. Our ambition is to become a focused & innovative player targeting rare cancers. Neurology will constitute a future growth driver. In all these areas, we take patient considerations into account at every stage of the drug life cycle.
--
To report a suspected adverse event with our drug, please visit servier.com
Joined 7 April 2014